サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494308

北米のdPCR・qPCR市場予測（～2030年）：地域別分析 - 治療、製品、用途、エンドユーザー別

North America dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

出版日
ページ情報
英文 97 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
北米のdPCR・qPCR市場予測（～2030年）：地域別分析 - 治療、製品、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 97 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のdPCR・qPCRの市場規模は、2022年に35億5,108万米ドルに達し、2022年～2030年にCAGR9.7%で成長し、2030年には74億2,903万米ドルに達すると予測されています。

遺伝病と感染症の増加が北米のdPCR・qPCR市場を牽引

National Organizationの遺伝性疾患または先天性障害に関する情報によると、個々の遺伝性疾患はまれですが、全体として遺伝性疾患と診断される人は1万5,500人を超えます。2022年、MJH Life Sciences（米国）の報告書によると、世界では毎年30万人の新生児が鎌状赤血球症で生まれ、世界人口の5％を占めると推定されています。米国では、鎌状赤血球症は最も一般的な遺伝性疾患のひとつです。また、CDCによると、アフリカ系アメリカ人の500人に1人が鎌状赤血球症を患っており、12人に1人が常染色体劣性変異を患っています。COVID-19の発生はポリメラーゼ連鎖反応市場の成長に大きな影響を与えました。臨床診断市場における需要の増大はPCR産業に好影響を与えています。ほぼすべての診断検査はRT-PCRを使ってCOVID-19の症状があり、ヘルスケア専門家から診断検査を受けるよう促された人々を検査しますが、 当局はウイルス培養検査を支持していませんでした。バイオテクノロジーや製薬企業の大半は、COVID-19に対する新規化合物や治療法の発見に向け、研究開発部門に力を注いでいました。2022年2月、ロシュはCE認証を受け入れる国で使用するCOVID-19向けPCRのポートフォリオに、新たにリリースされた分子検査機器であるコバス5800システムを追加しました。これらの製品には、コバスSARS-CoV-2・インフルエンザA/B検査、コバスSARS-CoV-2定性検査が含まれます。ロシュ・ダイアグノスティックスは、これらの製品により、少量、中量、多量の分子検査ニーズに均一な性能と効率性を提供することで、分子検査製品ラインアップの幅を広げています。さらに、スペースやリソースが限られているヘルスケア機関でも、コンパクトな新型コバス5800システムにより、包括的なアクセスが可能になります。リソースやスペースの不足のために大型の装置を設置できない国や環境では、検査へのアクセス性が向上します。

このように、dPCR・qPCR技術を診断や治療に使用できる遺伝性疾患や感染性疾患の発生率が増加していることが、北米のdPCR・qPCR市場の成長を支えています。

北米のdPCR・qPCR市場概要

北米のdPCR・qPCR市場は、米国、カナダ、メキシコに区分されます。北米はバイオテクノロジー最大の市場であり、米国が最大の市場シェアを占め、カナダがこれに続いています。北米の市場成長の背景には、バイオ分析機器メーカーやPCR企業による革新的な製品に対する需要の増加、主要な市場企業の存在、さまざまな学術・研究機関で行われる広範な研究開発があります。ヘルスケアにおける高度な手法の導入への注目の高まり、精密医療を推進するための政府・民間のイニシアティブ、ゲノム研究のための政府・民間団体からの巨額の資金も、北米のdPCR・qPCR市場の成長を刺激し、卓越した収益創出に貢献すると期待されています。さらに、同国の様々な研究グループによる科学的進歩は、世界市場の位置付けにおける同地域の成長と優位性に対応しています。

北米のdPCR・qPCR市場の収益と2030年までの予測（金額）

北米のdPCR・qPCR市場のセグメンテーション

北米のdPCR・qPCR市場は、治療、製品、用途、エンドユーザー、国に基づいてセグメント化されます。

治療別では、北米のdPCR・qPCR市場は定量PCR（qPCR）とデジタルPCR（dPCR）に二分されます。2022年にはデジタルPCR（dPCR）セグメントのシェアが大きくなりました。

製品別では、北米のdPCR・qPCR市場は試薬・消耗品、機器、ソフトウェア・サービスに区分されます。2022年には試薬・消耗品セグメントが最大のシェアを占めました。

用途別では、北米のdPCR・qPCR市場は研究用途、臨床用途、法医学用途に区分されます。2022年には臨床応用セグメントが最大のシェアを占めました。臨床用途セグメントはさらに、腫瘍学検査、血液スクリーニング、感染症検査、その他の用途に細分化されます。

エンドユーザー別では、北米のdPCR・qPCR市場は、病院・診断センター、製薬・バイオテクノロジー企業、研究・学術機関、法医学研究所、臨床研究機関に区分されます。病院・診断センターセグメントが2022年に最大シェアを占めました。

国別に見ると、北米のdPCR・qPCR市場は米国、カナダ、メキシコに区分されます。2022年の北米dPCR・qPCR市場は米国が独占しました。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Qiagen NV、Standard BioTools Inc、Lepu Medical Technology Beijing Co Ltd、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Agilent Technologies Incは、北米のdPCR・qPCR市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のdPCR・qPCR市場- 主要産業力学

  • 市場促進要因
    • 遺伝病・感染症の発生率の増加
    • 遺伝子合成への投資と資金の増加
    • PCR技術の技術的進歩
  • 市場抑制要因
    • PCRシステムの高コスト
    • qPCRに伴う技術的限界
  • 市場機会
    • 新興国におけるPCR法の採用拡大
  • 今後の動向
    • 液滴デジタルPCRの発展
  • 影響分析

第5章 dPCR・qPCR市場：北米市場分析

  • 北米のdPCR・qPCR市場収益（2022年～2030年）

第6章 北米のdPCR・qPCR市場 - 2030年までの収益と予測：治療別

  • 北米のdPCR・qPCR市場の収益シェア：治療別（2022年・2030年）
  • 定量PCR
  • デジタルPCR

第7章 北米のdPCR・qPCR市場 - 2030年までの収益と予測：製品別

  • 北米のdPCR・qPCR市場の収益シェア：製品別（2022年・2030年）
  • 試薬・消耗品
  • 装置
  • ソフトウェア・サービス

第8章 北米のdPCR・qPCR市場 - 2030年までの収益と予測：用途別

  • 北米のdPCR・qPCR市場の収益シェア：用途別（2022年・2030年）
  • 研究用途
  • 臨床用途
  • 法医学用途

第9章 北米のdPCR・qPCR市場 - 2030年までの収益と予測：エンドユーザー別

  • 北米のdPCR・qPCR市場の収益シェア：エンドユーザー別（2022年・2030年）
  • 病院・診断センター
  • 製薬会社・バイオテクノロジー企業
  • 研究・学術機関
  • 法医学研究所
  • 臨床研究機関

第10章 北米のdPCR・qPCR市場：国別分析

    • 北米のdPCR・qPCR市場：国別
      • 米国
      • カナダ
      • メキシコ

第11章 dPCR・qPCR市場-業界情勢

  • 北米dPCR・qPCR市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc

第13章 付録

図表

List Of Tables

  • Table 1. North America dPCR and qPCR Market Segmentation
  • Table 2. North America dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Recent Organic Growth Strategies in North America dPCR and qPCR Market
  • Table 19. Recent Inorganic Growth Strategies in the North America dPCR and qPCR Market
  • Table 20. Glossary of Terms, North America dPCR and qPCR Market

List Of Figures

  • Figure 1. North America dPCR and qPCR Market Segmentation, By Country
  • Figure 2. North America dPCR and qPCR Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 6. Quantitative PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Digital PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 9. Reagents & Consumables: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Software & Services: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 13. Research Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Clinical Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Forensic Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 17. Hospitals and Diagnostic Centers: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Research Laboratories and Academic Institutes: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Forensic Laboratories: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Clinical Research Organizations: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: North America dPCR and qPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in North America dPCR and qPCR Market
目次
Product Code: BMIRE00029878

The North America dPCR and qPCR market was valued at US$ 3,551.08 million in 2022 and is expected to reach US$ 7,429.03 million by 2030; it is estimated to grow at a CAGR of 9.7% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive North America dPCR and qPCR Market

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In 2022, a report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year, accounting for ? 5% of the global population. In the US, it is one of the most prevalent genetic conditions. Also, 1 in 500 African Americans is affected by sickle cell disease, and ? 1 in 12 of them suffers from the autosomal recessive mutation, according to the CDC. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium-, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space.

Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the North America dPCR and qPCR market.

North America dPCR and qPCR Market Overview

The North America dPCR and qPCR market in North America is segmented into the US, Canada, and Mexico. North America is the largest market for biotechnology, with the US holding the largest market share, followed by Canada. The market growth in North America is attributed to an increase in the demand for innovative products from bio-analytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. The increasing focus on advanced method incorporation in healthcare, government and private initiatives for promoting precision medicine, and massive funds from government and private bodies for genomic research are also expected to stimulate the growth and contribute to exceptional revenue generation for the North America dPCR and qPCR market in North America. Additionally, scientific advances made by various research groups in the country correspond to the growth and dominance of the region in the global market positioning.

North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

North America dPCR and qPCR Market Segmentation

The North America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the North America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the North America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the North America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the North America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the North America dPCR and qPCR market is segmented into segmented into the US, Canada, and Mexico. The US dominated the North America dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the North America dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America dPCR and qPCR Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 4.1.2 Rising Investments and Funds for Gene Synthesis
    • 4.1.3 Technological Advancements in PCR Technologies
  • 4.2 Market Restraints
    • 4.2.1 High Costs of PCR Systems
    • 4.2.2 Technical Limitations Associated with qPCR
  • 4.3 Market Opportunities
    • 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 4.4 Future Trends
    • 4.4.1 Development of Droplet Digital PCR
  • 4.5 Impact Analysis:

5. dPCR and qPCR Market - North America Market Analysis

  • 5.1 North America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 6.3 Quantitative PCR
    • 6.3.1 Overview
    • 6.3.2 Quantitative PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Digital PCR
    • 6.4.1 Overview
    • 6.4.2 Digital PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 North America dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. North America dPCR and qPCR Market - Country Analysis

    • 10.1.1 North America dPCR and qPCR Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 US: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.1.3 US: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 US: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.1.5 US: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Canada: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Canada: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Canada: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.2.5 Canada: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Mexico: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Mexico: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 Mexico: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.3.5 Mexico: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in North America dPCR and qPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Standard BioTools Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms